ACELYRIN’s Merger with Alumis

Fenwick & West advised ACELYRIN, INC. on the transaction, and Cooley advised Alumis Inc. ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Bugcrowd’s Acquisition of Informer

Fenwick & West represented Bugcrowd in the transaction. Bugcrowd, a provider of crowdsourced security, announced its acquisition of Informer, a provider of external attack surface management...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here